Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 5Genitourinary 3CNS 3Tumor-Agnostic 2Sarcoma 2Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Gastrointestinal 2Dermatologic 2Breast 2Plasma cell 1Other solid neoplasm 1Other 1Endocrine 1

Conditions

Melanoma 2Pain 1Lymphedema 1Depression 1Cicatrix 1Anxiety Disorders 1

Interventions

Ipilimumab 123pembrolizumab 101Nivolumab 100aldesleukin 89Cyclophosphamide 85fludarabine phosphate 64Interleukin-2 58Dacarbazine 573-ingenyl angelate 42Vemurafenib 39Temozolomide 39Imiquimod 39trametinib 37sargramostim 37Peripheral Blood Stem Cell Transplantation 36incomplete Freund's adjuvant 35dabrafenib 32fludarabine 31Radiotherapy 31Aminolevulinic Acid 30Bevacizumab 29Carboplatin 28Whole-Body Irradiation 25Photochemotherapy 25Paclitaxel 25Filgrastim 25Biopsy 25Interferon-alpha 24Cisplatin 23Sorafenib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Restraint, Physical × Dermatologic × Clear all
NCT05027009 2022-06-09

Effects of Simulated Solar Radiation on Human Skin in Preventing Skin Cancer

OHSU Knight Cancer Institute

Phase NA Completed
6 enrolled
Dermatologic

Melanoma

NCT02352623 2016-05-26

Quality of Life and Surgical Late Effects of Melanoma Treatment

Herlev Hospital

Completed
435 enrolled
Dermatologic

Anxiety Disorders, Cicatrix, Depression, Lymphedema, Melanoma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡